50242-0070 Gazyva - CanMED: NDC

Product NDC:

50242-0070

Brand Name:

Gazyva

Generic Name:

Obinutuzumab

Dosage Form Name:

INJECTION, SOLUTION, CONCENTRATE

Administration Route:

Intravenous

Substances:

Name: Obinutuzumab

Strength: 1000.0

Unit: mg/40mL

Packages:

Code: 50242-0070-01

Description: 1 VIAL, SINGLE-USE in 1 CARTON (50242-070-01) / 40 mL in 1 VIAL, SINGLE-USE

Effective Date: Nov. 1, 2013

Discontinued:

Code: 50242-0070-86

Description: 1 VIAL, SINGLE-USE in 1 CARTON (50242-070-86) / 40 mL in 1 VIAL, SINGLE-USE

Effective Date: Nov. 4, 2013

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

CD20

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox